Of these readings, 26,664 were identified as being hypoglycaemic (<4 mmol/L) from individuals with T1DM, 23,591 from individuals with T2DM on insulin and 30,344 from individuals with T2DM on sulphonylurea therapy. This evidence concerns the gene INS and type 2 diabetes mellitus.